CDK4 and breast carcinoma: TIS was also observed in breast cancer, Ewing sarcoma, and neuroblastoma following treatment with CDK4/6 inhibitors 86, or in lung cancers and pancreatic cancers following treatment with MEK and CDK4/6 inhibitors 11, 87-90.